期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

针对20S蛋白酶体的抗肿瘤药物研究进展 被引量：4

下载PDF
导出
摘要 20S蛋白酶体在生物体内的功能主要是水解蛋白,其与许多疾病如阿尔斯海默症、癌症等有密切的相关性,已经成为抗肿瘤药物研发的新靶点。本文对已经上市的硼替佐米、卡非佐米及正在临床研究阶段的Marizomib的结构及应用特点进行综述。
作者 邢志佳 张叶叶 马宇衡 杨慧
机构地区 内蒙古医科大学药物化学教研室
出处 《天津药学》 2015年第1期55-57,共3页 Tianjin Pharmacy
关键词 20S蛋白酶体 抑制剂 硼替佐米 卡非佐米 Marizomib
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献31

  • 1Coux O, Tanaka K, Goldberg A L. Structure and functions of the 20S and 26S proteasomes[J]. Annu Rev Biochem, 1996,65:801 -847.
  • 2Kim H M, Yu Y, Cheng Y. Structure characterization of the 26S pro- tcasome [ J ]. Biochim Biophys Acta, 2011,1809 (2) :67 - 79.
  • 3Bedford L, Paine S, Sheppard P W, et al. Assembly structure and function of the 26S proteasome [ J]. Trends Cel Biol,2010,20 (7) : 391 -401.
  • 4Verdoes M, Florea B I, Marel G, et al. Chemical tools to study the proteasome [ J ]. Eur J Org Chem, 2009,20:3301 - 3313.
  • 5Tsvetkov P, Reuven N, Shaul Y. Ubiquitin - independert p53 protea- somal degradation [J]. Cell Death Differ, 2009,17( 1 ) : 103 - 108.
  • 6Loidl G, Groll M, Musiol H J, et al. Bifunctional inhibitors of the tryp- sin - like activity of eukaryotic proteasomes [ J ]. Chem Biol, 1999,6 (4) :197 -204.
  • 7Groll M, Berkers C R, Ploegh H L, et al. Crystal structure of the bn- tonic acid- based proteasome inhibitor bortezomib in complex with theyeast 20S proteasome [ J ]. Structure, 2006,14 (3) :451 - 456.
  • 8Meng L, Mohan R, Kwok B H, et al. Epoxomicin, a potent and selec- tive proteasome inhibitor, exhibits in vivo anti - inflammatory activity [J]. Proc Natl Acad Sci USA, 1999,96(18) :10403 - 10408.
  • 9Palmer J T, Rasnick D, Klaus J L, et al. Vinyl sulfones as mechanism- based cysteine protease inhbibitors [ J]. J Med Chem, 1995,38(17) :3193 -3196.
  • 10李景,张大永,吴晓明.泛素-蛋白酶体及其抑制剂的分类与合成[J].药学学报,2009,44(12):1313-1319. 被引量：2

二级参考文献142

  • 1Wei-GuoZhang,Jie-PingYu,Qing-MingWu,QiangTong,Sheng-BaoLi,Xiao-HuWang,Guo-JianXie.Inhibitory effect of ubiquitin-proteasome pathway on proliferation of esophageal carcinoma cells[J].World Journal of Gastroenterology,2004,10(19):2779-2784. 被引量：7
  • 2王维,罗和生.核因子-κB抑制剂逆转人胃癌细胞对长春新碱耐药性的研究[J].中华肿瘤杂志,2005,27(6):335-338. 被引量：5
  • 3刘国红,王苏荣,王波.核因子-κB在P-糖蛋白介导卵巢癌细胞多药耐药性中的作用[J].基础医学与临床,2006,26(2):187-191. 被引量：5
  • 4Bahlis N J, Cafferty-Grad J, Jordan-McMurry I, et al. Feasibility and correlates of arsenic trioxide combined with ascorbic acid-media|ed depletion of intracellular glutathione for the treatment of relapsed/re- fractory multiple myeloma[ J]. Clin Cancer Res,2002,8 (12) :3658.
  • 5Berenson JR, Boccia R,Siegel D, et al. Efficacy and safety of melpha- lan ,arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma:a prospective, muhicen- tre,phase Ⅱ , single - arm study [ J ]. Br J Haematol, 2006,135 ( 2 ) : 174.
  • 6Hideshima T, Mitsiades C, Tonon G, et al. Understanding muhiple my- eloma pathogenesis in the bone marrow to identify new therapeutic tar- gets[J]. Nat Rev Cancer,2007,7(8) :585.
  • 7Manges RF, Sutherland HJ, Jagannath S, et al. Preliminary results of CNTO 328, an anti-interleukin (IL) -6 monoclonal antibody ( mAb), in combination with bortezomib in the treatment of relapsed or refrac- tory multiple myeloma [J].Blood,2007,110 ( abstr ) : 1183.
  • 8Mateo G, Montalban MA, Vidriales MB, et al. Prognostic value of im- munophenotyping in multiple myeloma: a study by the PETHEMA/ GEM cooperative study groups on patients uniformly treated with high- dose therapy[J].J Clin Oneol,2008,26(16) :2737.
  • 9Chanan-Khan AA, Jagannath S, Munshi NC, et al. Phase I study of huN901-DM1 (BB-10901) in patients with relapsed and relapsed/refractory CD56-positive multiple myeloma [ J ]. Blood, 2007, 110 (abstr) : 1174.
  • 10Tai YT,Dillon M,Song W,et al. Anti-CS1 humanized monoclonal an- tibody HuLuc63 inhibits myeloma cell adhesion and induces antibody- dependent cellular cytotoxicity in the bone marrow milieu[J]. Blood, 2008,112(4) :1329.

共引文献49

同被引文献35

引证文献4

二级引证文献3

天津药学
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部